0000000000230932

AUTHOR

Claudia Korandji

showing 8 related works from this author

Symmetric dimethylarginine serum level as a new marker of left ventricular ejection fraction in patients with acute myocardial infarction

2013

Purpose: Asymmetric dimethylarginine (ADMA) is a by-product of protein methylation that has been implicated in the prognosis after acute myocardial infarction (MI) and heart failure through Nitric Oxide Synthase (NOS) inhibition. We aimed to investigate whether SDMA – the endogenous symmetrical stereoisomer of ADMA- that has insignificant inhibitory effects on NOS- might be a marker of left ventricular function in acute MI. Methods: Blood samples from 635 consecutive patients hospitalized 1 (23%). Mean LVEF was 55±13%. Mean ADMA, SDMA and L-arg levels were at 0.72±0.42, 0.51±0.44 and 91±54 μmol/L, respectively. Spearman analysis showed that LVEF was correlated negatively with SDMA (r=-0.151…

medicine.medical_specialtyEjection fractionbiologyHomocysteinebusiness.industryRenal functionmedicine.diseaseTroponinchemistry.chemical_compoundBlood pressurechemistryHeart failureInternal medicinemedicinebiology.proteinCardiologycardiovascular diseasesMyocardial infarctionCardiology and Cardiovascular MedicineAsymmetric dimethylargininebusinessEuropean Heart Journal
researchProduct

Impact of asymmetric dimethylarginine on mortality after acute myocardial infarction.

2008

Objective— Asymmetrical dimethylarginine (ADMA) is an endogenous competitive inhibitor of nitric oxide (NO) synthases. From a prospective cohort of patients with acute myocardial infarction (MI), we aimed to analyze the predictive value of circulating ADMA concentrations on prognosis. Methods and Results— Blood samples from 249 consecutive patients hospitalized for acute MI <24 hours were taken on admission. Serum levels of ADMA and its stereoisomer, symmetrical dimethylarginine (SDMA), were determined using high-performance liquid chromatography. The independent predictors of ADMA were glomerular filtration rate, female sex, and SDMA ( R 2 =0. 25). Baseline ADMA levels were higher in p…

Malemedicine.medical_specialtyMyocardial InfarctionRenal functionArginineNitric oxideCohort Studieschemistry.chemical_compoundInterquartile rangePredictive Value of TestsInternal medicinemedicineHumansMyocardial infarctionProspective StudiesProspective cohort studyAgedAged 80 and overbusiness.industryHazard ratioConfoundingMiddle Agedmedicine.diseasePrognosisSurgerychemistryCardiologyRegression AnalysisFemaleCardiology and Cardiovascular MedicineAsymmetric dimethylargininebusinessBiomarkersFollow-Up StudiesArteriosclerosis, thrombosis, and vascular biology
researchProduct

Anti-hypertensive effects of Rosuvastatin are associated with decreased inflammation and oxidative stress markers in hypertensive rats

2009

International audience; Among their pleiotropic effects, statins exert antioxidant and anti-inflammatory properties. The aim of this study was to evaluate in normotensive (WKY) and in spontaneously hypertensive rats (SHR) the effect of rosuvastatin (ROSU) treatment on (1) plasma inflammation markers and endogenous NO synthase inhibitor (ADMA) levels, (2) reactive oxygen species (ROS) generated by circulating leukocytes and (3) vascular oxidative stress and tissue inflammation markers. Plasma cytokines were higher in SHR than in WKY, except for IL-4, which was lower in SHR than in WKY. SHR monocytes exhibited higher production of ROS than did WKY monocytes. In the experimental conditions, RO…

MaleAntioxidantmedicine.medical_treatmentBlood Pressure030204 cardiovascular system & hematologymedicine.disease_causeBiochemistryRats Inbred WKYchemistry.chemical_compound0302 clinical medicineRats Inbred SHR[SDV.IDA]Life Sciences [q-bio]/Food engineeringRosuvastatin CalciumComputingMilieux_MISCELLANEOUSchemistry.chemical_classification0303 health sciencesSulfonamidesGeneral Medicine3. Good healthNAD(P)H oxidasecardiovascular systemmedicine.symptommedicine.drugmedicine.medical_specialtyhypertensionleukocytesInflammationArgininestatins03 medical and health sciences[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemInternal medicinemedicineAnimalsRosuvastatin[SPI.GPROC]Engineering Sciences [physics]/Chemical and Process Engineeringcardiovascular diseasesAntihypertensive Agents030304 developmental biologyInflammationReactive oxygen speciesCholesterolNAD(P)H oxidaseNADPH OxidasescytokinesRatsFluorobenzenesOxidative StressEndocrinologyBlood pressurePyrimidineschemistryInterleukin-4Hydroxymethylglutaryl-CoA Reductase InhibitorsReactive Oxygen SpeciesOxidative stress
researchProduct

Asymmetric dimethylarginine (ADMA) and hyperhomocysteinemia in patients with acute myocardial infarction

2006

We sought to investigate the association between increased levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, and total plasma homocysteinemia (tHcy) in patients with acute myocardial infarction (AMI).In 138 patients hospitalized for AMI24 h on admission, serum levels of ADMA, its symmetric stereoisomer (SDMA) and tHcy were measured.ADMA was positively associated with SDMA (p0.001) and tHcy (p=0.03) but not with estimated glomerular filtration rates (eGFR, p=0.96), while tHcy strongly correlated with eGFR (p=0.002) and SDMA (p0.001). By multiple linear regression, SDMA but not ADMA was independently associated with tHcy (p=0.005).Our findings sugges…

Malemedicine.medical_specialtyHyperhomocysteinemiaHomocysteineClinical BiochemistryCardiovascular risk factorsHyperhomocysteinemiaMyocardial InfarctionRenal functionArginineStatistics Nonparametricchemistry.chemical_compoundRisk FactorsInternal medicinemedicineHumansIn patientcardiovascular diseasesMyocardial infarctionHomocysteineAgedbusiness.industryStereoisomerismGeneral MedicineMiddle Agedmedicine.diseaseEndocrinologychemistryRisk indicatorCardiologyRegression AnalysisFemalebusinessAsymmetric dimethylarginineClinical Biochemistry
researchProduct

Short-term atorvastatin treatment does not modify neointimal morphology but reduces MMP-2 expression in normocholesterolemic rabbit stented arteries.

2006

The aim of our study was to explore some potential pleiotropic effects of atorvastatin, after stenting in the iliac arteries of normocholesterolemic rabbits. On day 0, 27 rabbits underwent stent implantation and were randomized into either the control group (standard chow, CTRL, n = 15) or the atorvastatin group (10 mg/kg/d per os, Ator, n = 12). On day 30, the stented arteries were harvested for histomorphometry and neointimal analysis [macrophages, matrix metalloproteinases (MMP-2), tissue inhibitor of metalloproteinase-2, vascular smooth muscle cells, and collagen]. Atorvastatin did not induce significant histomorphometric and inflammatory modifications but reduced neointimal expression …

NeointimaMalemedicine.medical_specialtyStatinVascular smooth musclemedicine.drug_classAtorvastatinHypercholesterolemiaUrologyMatrix metalloproteinaseIliac ArteryMuscle Smooth VascularRestenosisInternal medicinemedicineAtorvastatinAnimalsPyrrolesPharmacologyTissue Inhibitor of Metalloproteinase-2Cellular densityChemistrymedicine.diseaseImmunohistochemistryHeptanoic AcidsCardiologyMatrix Metalloproteinase 2StentsStatin therapyRabbitsHydroxymethylglutaryl-CoA Reductase InhibitorsCardiology and Cardiovascular MedicineTunica Intimamedicine.drugJournal of cardiovascular pharmacology
researchProduct

Combining Sirolimus-eluting Stents and External Irradiation in Cholesterol-fed Rabbits Increased Incomplete Stent Apposition and Decreased Re-endothe…

2009

Restenosis after the implantation of a drug-eluting stent or after vascular irradiation therapy shares similar physiopathological mechanisms. No experimental data are currently available on vascular wall behavior after external irradiation on arteries stented with sirolimus-eluting stents (SES). Ten New Zealand white rabbits received a 0.5% cholesterol-enriched chow for 1 month. Bilateral iliac artery stent implantation was then performed with an SES (Cypher; Cordis Corp). The animals were randomized into either an irradiated group (I, 2 Gy external x-ray irradiation, n = 5) or a control group (C, n = 5). The cholesterol-enriched chow was continued for 1 additional month after stent implant…

Malemedicine.medical_specialtyTime FactorsEndotheliummedicine.medical_treatmentUrologyCholesterol Dietarychemistry.chemical_compoundRestenosismedicineAnimalsSirolimusPharmacologyCholesterolbusiness.industryX-RaysStentDose-Response Relationship RadiationDrug-Eluting StentsIncomplete stent appositionequipment and suppliesmedicine.diseaseImmunohistochemistryPathophysiologySurgeryStenosisCholesterolmedicine.anatomical_structurechemistrySirolimusEndothelium VascularRabbitsTunica IntimaTunica MediaCardiology and Cardiovascular MedicinebusinessImmunosuppressive Agentsmedicine.drugJournal of Cardiovascular Pharmacology
researchProduct

High Levels of Asymmetric Dimethylarginine Are Strongly Associated with Low HDL in Patients with Acute Myocardial Infarction

2013

International audience; Objectives: Low levels of high-density lipoprotein (HDL) cholesterol are associated with an increased risk of acute myocardial infarction possibly through impaired endothelial atheroprotection and decreased nitric oxide (NO) bioavailability. Asymmetric dimethylarginine (ADMA) mediates endothelial function by inhibiting nitric oxide synthase activity. In patients with acute myocardial infarction, we investigated the relationship between serum levels of HDL and ADMA. Approach and Results: Blood samples from 612 consecutive patients hospitalized for acute MI ,24 hours after symptom onset were taken on admission. Serum levels of ADMA, its stereoisomer, symmetric dimethyl…

MaleArginineEpidemiologyMyocardial Infarctionlcsh:Medicine030204 cardiovascular system & hematologyCardiovascularBiochemistrychemistry.chemical_compound0302 clinical medicineMedicineMyocardial infarctionlcsh:ScienceChromatography High Pressure Liquid0303 health sciencesMultidisciplinarybiologyNeurochemistryMiddle Aged[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system3. Good healthNitric oxide synthaseBlood ChemistryMedicinelipids (amino acids peptides and proteins)FemaleNeurochemicalsLipoproteins HDLResearch Articlemedicine.medical_specialtyClinical Research DesignLipoproteinsNitric OxideArginineNitric oxide03 medical and health sciences[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemInternal medicineHumansBiologyCardiovascular Disease Epidemiology030304 developmental biologyAgedPopulation Biologybusiness.industryCholesterollcsh:RProteinsmedicine.diseaseBioavailabilityBiomarker EpidemiologyEndocrinologychemistrybiology.proteinlcsh:QbusinessAsymmetric dimethylarginineLipoproteinNeurosciencePLoS ONE
researchProduct

Time course of asymmetric dimethylarginine (ADMA) and oxidative stress in fructose-hypertensive rats: A model related to metabolic syndrome

2011

Asymmetric dimethylarginine (ADMA) is an endogenous modulator of endothelial function and oxidative stress, and increased levels of this molecule have been reported in some metabolic disorders and cardiovascular diseases. The aim of this work was to analyze the time course of dimethylarginine compounds and oxidative stress levels and the relationship between these and cardiovascular function in fructose-hypertensive rats.90 male Sprague-Dawley rats were randomized into 2 groups, fed for 3 months with standard (C) chow supplemented or not with fructose (F, 60%). After sacrifice at different weeks (W), the aorta and plasma were harvested to assess the vascular and biochemical parameters. Our …

Blood GlucoseMaleTime FactorsVasodilator AgentsNitric Oxide Synthase Type IIBlood Pressure030204 cardiovascular system & hematologymedicine.disease_causeRats Sprague-Dawleychemistry.chemical_compound0302 clinical medicineHeart RateEnzyme InhibitorsAortaComputingMilieux_MISCELLANEOUSMetabolic Syndrome0303 health sciencesOxidase testVasodilationNAD(P)H oxidaseHypertensionCardiology and Cardiovascular Medicinemedicine.medical_specialtyFructoseArginine03 medical and health sciences[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemInternal medicinemedicine.arterymedicineAnimals030304 developmental biologyAortaDose-Response Relationship Drugbusiness.industryVascular diseaseBody WeightNADPH OxidasesFructosemedicine.diseaseRatsDisease Models AnimalOxidative StressEndocrinologychemistryTyrosineMetabolic syndromebusinessAsymmetric dimethylarginineOxidative stressAtherosclerosis
researchProduct